However, analyzing the thrombo-pathological characteristics of patients with AIS who received RS vs. NRS showed significant differences in the expression of biomarkers associated with AIS and thrombosis, such as CD163, NET, and CRP, between the two patient groups. This evidence concerns the gene CD163 and Venous thrombosis.